MedTrace Logo

Expression of Fas Protein in Skin Biopsies of Participants With Scarring Alopecia

NCT00691769 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 8

Last updated 2018-07-06

No results posted yet for this study

Summary

The purpose of this research study is to see if a specific protein that we are interested in is involved in scarring hair loss. If these proteins are involved, further genetic work may also better define the disease as well as future treatment options.

Conditions

  • Central Centrifugal Scarring Alopecia
  • Lichen Planopilaris
  • Discoid Lupus Erythematosus

Sponsors & Collaborators

  • Wake Forest University

    lead OTHER

Principal Investigators

  • Amy McMichael, MD · Wake Forest University Health Sciences

Eligibility

Min Age
30 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-04-26
Primary Completion
2012-11-26
Completion
2012-11-26

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00691769 on ClinicalTrials.gov